Faculty profile for Dr. Christopher D. Blosser. Dr. Blosser is a transplant nephrologist and medical director of the Cancer ...

Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Fred Hutch board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only ...

Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

In just 50 years, Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for its expertise in molecular biology, tumor virology and ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer, day in and day out. A handful of people form the core of your care team. You have an oncologist who ...